Effectiveness of Motivational Interviewing Supervision in Community Programs

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The virtual requirement that substance abuse programs use evidence-based treatments (EBT) has prompted the development of dissemination strategies to promote EBT technology transfer. Implementation research, clinical trial training methods, and clinician training studies suggest that clinical supervision that involves direct observation, fidelity rating-based feedback, and coaching of therapeutic skills is a promising dissemination approach. However, clinical supervision delivered within substance abuse programs by on-site supervisors has never been directly tested in a randomized controlled trial to determine the impact of supervision on both clinician EBT skills and client treatment outcomes.

Recent results from two NIDA CTN protocols testing the effectiveness of Motivational Interviewing (MI) have shown that community program clinicians can learn to deliver MI with fidelity when receiving MI supervision from their program supervisors after workshop training and that their implementation of MI early in treatment improves client retention and primary substance use outcomes. A MI supervision manual called MIA: STEP (Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency) was developed from these protocols and has begun to be widely distributed by NIDA in partnership with SAMHSA for community program use. The effectiveness of the MIA: STEP supervision approach is unknown.

This study will directly test the effectiveness of MIA: STEP supervision on clinician MI fidelity and on client outcomes by randomly assigning 60 clinicians and 420 substance-using outpatients from 11 community programs within Connecticut to one of two conditions in which clinicians in both conditions will deliver a 1-session MI intervention to clients as the enter treatment. The conditions are: 1) workshop training plus MIA: STEP supervision, and 2) workshop training alone with supervision-as-usual practices used at each program. This project will be the first randomized trial to examine the impact of clinical supervision in an empirically based treatment on both clinician and client outcomes. Moreover, because it will provide workshop training and supervision completely within the context of community programs and utilize in-house program supervisors, it will provide a rigorous evaluation of a feasible model for disseminating EBTs such as MI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Training Clinicians in Motivational Interviewing

NCT01065480

Substance Abuse

COMPLETED NA

Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

NCT00032994

Substance-Related Disorders

COMPLETED PHASE3

Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1

NCT00086398

Substance-Related Disorders

UNKNOWN PHASE2

Motivational Assessment Program to Initiate Treatment

NCT01891656

Substance-Related Disorders

COMPLETED NA

Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

NCT00032981

Substance-Related Disorders

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Signs and Symptoms Clinical Supervision

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MIA: STEP

Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency (MIA: STEP)

Group Type EXPERIMENTAL

MIA: STEP

Intervention Type BEHAVIORAL

Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency (MIA: STEP

Supervision-as-usual

Supervision-as-usual consists of the typical clinical supervision services provided to clinicians by their supervisors in their community programs.

Group Type ACTIVE_COMPARATOR

SAU

Intervention Type BEHAVIORAL

Supervision-as-usual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SAU

Supervision-as-usual

Intervention Type BEHAVIORAL

MIA: STEP

Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency (MIA: STEP

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18 or older who work at one of the 12 participating programs
* willing to serve as study clinicians and learn the MI assessment intake
* working at least 20 hours per week at the program
* are not intending to give notice to their employer that they intend to leave the agency or are not scheduled for medical or family leave during the study period
* willing to record clinical sessions for review by the MI expert and/or independent raters
* willing to have supervision sessions recorded if randomized to MIA: STEP condition
* deemed capable by program administrative leadership to manage the responsibilities of being a clinician in a randomized trial

* English-speaking
* seeking non-opiate replacement outpatient treatment for any substance use problem and have used primary substance (alcohol or illicit drug) at least once in the prior 28 days
* 18 years of age or older
* willing to participate in the protocol (randomization to clinicians contact for follow-up assessments, MI session recording for supervisor and independent review)

Exclusion Criteria

* served as MI therapists in prior clinical trial studies.
* received formal supervision in MI based on direct observation, session ratings, and related feedback and coaching.
* trained as MI trainers through the Motivational Interviewing Network of Trainers (MINT).

For Clients

* insufficiently medically or psychiatrically stable to participate in outpatient treatment.
* highly unlikely to be reached for follow-up due to residential instability or imminent incarceration.
* seeking detoxification only, opiate replacement treatment, or residential inpatient treatment.

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No